Decoy Therapeutics Inc
(DCOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,936 | -1,670 | -34,434 | -39,493 | -29,142 |
| Depreciation Amortization | 127 | 17 | 256 | 293 | 59 |
| Accounts receivable | 1 | N/A | 2 | -12 | N/A |
| Accounts payable and accrued liabilities | -519 | -286 | 819 | 309 | 621 |
| Other Working Capital | -4,212 | 5,799 | 2,234 | 571 | 1,735 |
| Other Operating Activity | -41 | 316 | 3,400 | 6,279 | 5,980 |
| Operating Cash Flow | $-11,580 | $4,177 | $-27,722 | $-32,052 | $-20,746 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 24,598 | -11,687 | -27,000 |
| PPE Investments | N/A | N/A | -108 | -554 | -266 |
| Net Acquisitions | 204 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 5,404 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $5,608 | $N/A | $24,490 | $-12,241 | $-27,265 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,131 | 2,050 | 3 | 22 | 80,844 |
| Dividend Paid | -134 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -418 | -615 | 0 | 0 | 0 |
| Financing Cash Flow | $3,579 | $1,435 | $3 | $22 | $80,844 |
| Beginning Cash Position | 6,132 | 519 | 22,543 | 66,814 | 33,854 |
| End Cash Position | 3,739 | 6,132 | 19,313 | 22,543 | 66,687 |
| Net Cash Flow | $-2,393 | $5,612 | $-3,230 | $-44,271 | $32,833 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,580 | 4,177 | -27,722 | -32,052 | -20,746 |
| Capital Expenditure | N/A | N/A | -114 | -559 | -266 |
| Free Cash Flow | -11,580 | 4,177 | -27,836 | -32,612 | -21,012 |